KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 77 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $12,000 | +71.4% | 2,000 | +150.0% | 0.01% | 0.0% |
| Q4 2018 | $7,000 | -50.0% | 800 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $14,000 | 0.0% | 800 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $14,000 | +27.3% | 800 | 0.0% | 0.01% | +25.0% |
| Q1 2018 | $11,000 | +37.5% | 800 | 0.0% | 0.00% | +33.3% |
| Q4 2017 | $8,000 | -11.1% | 800 | 0.0% | 0.00% | -25.0% |
| Q3 2017 | $9,000 | +28.6% | 800 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $7,000 | -30.0% | 800 | 0.0% | 0.00% | -40.0% |
| Q1 2017 | $10,000 | +25.0% | 800 | 0.0% | 0.01% | +25.0% |
| Q4 2016 | $8,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |